The Mexican pharmaceutical company Landsteiner signed an agreement with the Russian Direct Investment Fund for the delivery of 32 million doses, awaiting the approval of the Federal Commission for the Protection against Sanitary Risks (Cofepris).

 

The distribution of the “Sputnik” vaccine would take place in the month of November, authorization by “the Mexican government regulatory authorities” is expected, according to the state news agency, Sputnik.

 

The Ministry of Foreign Relations confirmed a week ago in a press release that based on the results of phases 1 and 2 of the Russian vaccine, phase 3 tests could be authorized in Mexico in 500 to 1,000 volunteers.

 

Also, the secretariat pointed out that the vaccine consists of two doses, after applying the first, a period of 21 days is necessary to apply the second dose.

 

The news of the acquisition of the Russian vaccine came one day after it was announced that the trials of the Oxford and AstraZeneca vaccine with Mexican participation were paused.

 

Due to the appearance of a potentially unexplained disease in one of the test subjects, “as part of the global controlled trials, our standard review process has paused vaccination to allow for review of safety data,” reported “AstraZeneca.”

 

With this, delays in the production of the AstraZeneca vaccine are foreseen, the Undersecretary of Prevention and Health Promotion Hugo López-Gatell pointed out that the protocol is common in the development of cradles when an unwanted reaction is detected, he said he did not know how long the suspension can last.

 

Sources: eluniversal.com, Forbes.com.mx